The government has announced plans to enhance the accessibility of life-saving medication for drug overdoses in homeless shelters and to the general public.
A consultation will be conducted to explore the provision of naloxone to hostels, day centers, and services catering to individuals experiencing rough sleeping or homelessness. Naloxone, a prescription-only medicine, can temporarily reverse opioid overdoses, allowing individuals crucial time to seek emergency medical care.
Additionally, the government will assess the possibility of supplying naloxone to emergency personnel at organizations like Border Force and the National Crime Agency. They will also consider new methods for accessing naloxone, such as installing accessible emergency boxes, similar to defibrillator cabinets, in high street areas and near nightlife venues.
Health Minister Karin Smyth emphasized the importance of naloxone, stating, “Every drug-related death is preventable. Naloxone is an effective medication that can reverse opioid overdoses, offering individuals the opportunity to seek treatment and rebuild their lives.”
Smyth added, “We aim to eliminate obstacles preventing the timely distribution of naloxone to those in critical need. This consultation aims to revise regulations and ensure that individuals who encounter opioids through their work or members of the public facing emergencies can potentially save lives.”
In a recent move, the government expanded the list of emergency service professionals authorized to provide take-home naloxone to include police officers, paramedics, and probation workers. By involving homeless charities, it is anticipated that more lives can be saved, aligning with the government’s commitment to allocate £3.4 billion for drug and alcohol treatment services.
According to the DHSC, drug-related deaths in England and Wales have doubled since 2012, with a record 5,448 lives lost last year. Notably, deaths involving nitazenes, a synthetic opioid, surged from 25 reported deaths in 2023 to 180 in 2024.
Sean Palmer, Executive Director of Strategy and Transformation at St Mungo’s, expressed support for the broader availability of naloxone, highlighting its significance in aiding people experiencing homelessness who use opioids. Palmer emphasized the life-saving impact of naloxone and its role in helping individuals recover and transition out of homelessness permanently.
He further stated, “Given the rising rates of opioid use and associated risks, naloxone is widely utilized across our services; our outreach teams are always equipped with it, and our staff are trained to respond to opioid overdoses, often saving lives in the process.
“We recognize that substance use can become a coping mechanism for individuals who feel they have limited options, especially for those with complex physical and mental trauma that is often both a cause and consequence of homelessness.